These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20869359)

  • 1. Investigation of urinary pteridine levels as potential biomarkers for noninvasive diagnosis of cancer.
    Gamagedara S; Gibbons S; Ma Y
    Clin Chim Acta; 2011 Jan; 412(1-2):120-8. PubMed ID: 20869359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of urinary pteridines by urine specific gravity for early cancer detection.
    Burton C; Shi H; Ma Y
    Clin Chim Acta; 2014 Aug; 435():42-7. PubMed ID: 24792383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pteridine detection in urine: the future of cancer diagnostics?
    Ma Y; Burton C
    Biomark Med; 2013 Oct; 7(5):679-81. PubMed ID: 24044558
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic profiling of pteridines for determination of potential biomarkers in cancer diseases.
    Kośliński P; Bujak R; Daghir E; Markuszewski MJ
    Electrophoresis; 2011 Aug; 32(15):2044-54. PubMed ID: 21563184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of urinary pteridine analysis conditions by CE-LIF for clinical use in early cancer detection.
    Gibbons SE; Stayton I; Ma Y
    Electrophoresis; 2009 Oct; 30(20):3591-7. PubMed ID: 19862738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of methotrexate, several pteridines, and creatinine in human urine, previous oxidation with potassium permanganate, using HPLC with photometric and fluorimetric serial detection.
    Durán Merás I; Espinosa Mansilla A; Rodríguez Gómez MJ
    Anal Biochem; 2005 Nov; 346(2):201-9. PubMed ID: 16213456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous urinary 3-hydroxyproline has 96% specificity and 44% sensitivity for cancer screening.
    Okazaki I; Matsuyama S; Suzuki F; Maruyama K; Maruta A; Kubochi K; Yoshino K; Kobayashi Y; Abe O; Tsuchiya M
    J Lab Clin Med; 1992 Dec; 120(6):908-20. PubMed ID: 1453112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of pteridines in biological samples with an emphasis on their stability.
    Tomšíková H; Tomšík P; Solich P; Nováková L
    Bioanalysis; 2013 Sep; 5(18):2307-26. PubMed ID: 24053245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple and useful method for evaluation of oxidative stress in vivo by spectrofluorometric estimation of urinary pteridines.
    Wakabayashi I; Nakanishi M; Ohki M; Suehiro A; Uchida K
    Sci Rep; 2020 Jul; 10(1):11223. PubMed ID: 32641855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in pteridine urinary levels in patients with malignant and benign ovarian tumors in comparison with healthy individuals.
    Zvarik M; Martinicky D; Hunakova L; Sikurova L
    J Photochem Photobiol B; 2015 Dec; 153():191-7. PubMed ID: 26414289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pteridine pattern in the urine of swine of different breeds and halothane genotypes in relation to nutrition and stress].
    Goldberg M; Eichinger H; Otten W; Merkenschlager M
    Tierarztl Prax; 1991 Oct; 19(5):493-6. PubMed ID: 1759264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neopterin, a biochemical indicator of cellular immune reactions, in the detection and control of patients with neoplastic diseases.
    Hausen A; Bichler A; Fuchs D; Hetzel H; Reibnegger G; Wachter H
    Cancer Detect Prev; 1985; 8(1-2):121-8. PubMed ID: 4064032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography.
    Zheng YF; Xu GW; Liu DY; Xiong JH; Zhang PD; Zhang C; Yang Q; Lv S
    Electrophoresis; 2002 Dec; 23(24):4104-9. PubMed ID: 12481266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.
    Woo HM; Kim KM; Choi MH; Jung BH; Lee J; Kong G; Nam SJ; Kim S; Bai SW; Chung BC
    Clin Chim Acta; 2009 Feb; 400(1-2):63-9. PubMed ID: 19010317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine interleukin-8 as a marker of vesicoureteral reflux in infants.
    Galanakis E; Bitsori M; Dimitriou H; Giannakopoulou C; Karkavitsas NS; Kalmanti M
    Pediatrics; 2006 May; 117(5):e863-7. PubMed ID: 16585276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pteridines in patients with different tumors.
    Zeitler HJ; Andondonskaja-Renz B
    Cancer Detect Prev; 1987; 10(1-2):71-9. PubMed ID: 3568011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy.
    Chan LW; Moses MA; Goley E; Sproull M; Muanza T; Coleman CN; Figg WD; Albert PS; Ménard C; Camphausen K
    J Clin Oncol; 2004 Feb; 22(3):499-506. PubMed ID: 14752073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanosine triphosphate cyclohydrolase I deficiency: early diagnosis by routine urine pteridine screening.
    Naylor EW; Ennis D; Davidson AG; Wong LT; Applegarth DA; Niederwieser A
    Pediatrics; 1987 Mar; 79(3):374-8. PubMed ID: 3822637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Increased urinary excretion of neopterin in patients with malignant tumors and with virus diseases (author's transl)].
    Wachter H; Hausen A; Grassmayr K
    Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1957-60. PubMed ID: 527945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations versus amounts of biomarkers in urine: a comparison of approaches to assess pyrethroid exposure.
    Fortin MC; Carrier G; Bouchard M
    Environ Health; 2008 Nov; 7():55. PubMed ID: 18983658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.